{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T15:32:04Z","timestamp":1794929524110,"version":"4.9.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T00:00:00Z","timestamp":1691625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T00:00:00Z","timestamp":1691625600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the fourth affiliated hospital of Harbin medical university special fund research projects","award":["HYDSYTB202228"],"award-info":[{"award-number":["HYDSYTB202228"]}]},{"name":"the important research and development projects in heilongjiang province","award":["Grant NO.JD22C007"],"award-info":[{"award-number":["Grant NO.JD22C007"]}]},{"name":"the Beijing Cihua Medical Development Foundation Project"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The differences in fat deposition sites exhibit varying degrees of systemic inflammatory responses and organ damage, especially in obese individuals with excessive visceral fat. Visceral fat, which is closely related to an increase in mortality rates related to heart and liver diseases. However, few studies have analysed the differences in heart and liver indicators and their correlation among groups based on the abdominal visceral fat area (AVFA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Clarifying the differences in and correlations of heart and liver indicators among groups with different severities of AVFA by magnetic resonance imaging (MRI).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Sixty-nine subjects with obesity were enrolled. The study group consisted of forty-one individuals (AVFA\u2009\u2265\u2009150\u00a0cm\n                      <jats:sup>2<\/jats:sup>\n                      ), and the control group consisted of twenty-eight individuals (100\u00a0cm\n                      <jats:sup>2<\/jats:sup>\n                      \u2009\u2264\u2009AVFA\u2009&lt;\u2009150\u00a0cm\n                      <jats:sup>2<\/jats:sup>\n                      ). The differences in and correlations between clinical, laboratory, and MRI indicators of the heart and liver between the two groups were analysed.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In the study group, the incidences of type 2 diabetes mellitus (T2DM) and insulin resistance were higher, and liver function indicators were worse. The left ventricular eccentricity ratio (LVER), left ventricular mass (LVM) and global peak wall thickness (GPWT) were higher in the study group than in the control group (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.002,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.001,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.03), and the left ventricle global longitudinal strain (LVGLS) was lower in the study group than in the control group (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.016). The pericardiac adipose tissue volume (PATV) and myocardial proton density fat fraction (M-PDFF) were higher in the study group than in the control group (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.001,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.001). The hepatic proton density fat fraction (H-PDFF) and abdominal subcutaneous fat area (ASFA) were higher in the study group than in the control group (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.012). There was a moderate positive correlation (\u03c1\u2009=\u20090.39\u20130.59,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001) between the AVFA and LVER, LVM, GPWT, LVGLS, and H-PDFF. There was no difference in right ventricular and most left ventricular systolic and diastolic function between the two groups.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The high AVFA group had a larger LVM, GPWT and PATV, more obvious changes in LVER, impaired left ventricular diastolic function, an increased risk of heart disease, and more severe hepatic fat deposition and liver injury. Therefore, there is a correlation between the amount of visceral adipose tissue and subclinical cardiac changes and liver injury.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12933-023-01926-0","type":"journal-article","created":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T12:01:54Z","timestamp":1691668914000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Correlation analysis of the abdominal visceral fat area with the structure and function of the heart and liver in obesity: a prospective magnetic resonance imaging study"],"prefix":"10.1186","volume":"22","author":[{"given":"Jinquan","family":"Bai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenzhou","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,10]]},"reference":[{"issue":"9","key":"1926_CR1","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.3390\/ijms20092358","volume":"20","author":"M Longo","year":"2019","unstructured":"Longo M, Zatterale F, Naderi J, et al. Adipose tissue dysfunction as determinant of obesity-associated metabolic complications. Int J Mol Sci. 2019;20(9):2358.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"1926_CR2","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1007\/s00392-020-01709-7","volume":"110","author":"P Kasper","year":"2021","unstructured":"Kasper P, Martin A, Lang S, et al. NAFLD and cardiovascular diseases: a clinical review. Clin Res Cardiol. 2021;110(7):921\u201337.","journal-title":"Clin Res Cardiol"},{"issue":"23","key":"1926_CR3","doi-asserted-by":"publisher","first-page":"17271","DOI":"10.1074\/jbc.R110.113175","volume":"285","author":"JE Hall","year":"2010","unstructured":"Hall JE, da Silva AA, do Carmo JM, et al. Obesity-induced hypertension: role of sympathetic nervous system, leptin, and melanocortins. J Biol Chem. 2010;285(23):17271\u20136.","journal-title":"J Biol Chem"},{"key":"1926_CR4","doi-asserted-by":"publisher","first-page":"14","DOI":"10.15829\/1560-4071-2016-4-14-18","volume":"4","author":"AV Ott","year":"2016","unstructured":"Ott AV, Chumakova GA, Veselovskaya NG. Resistance to leptin in development of different obesity phenotypes. Rus J Cardiol. 2016;4:14\u20138.","journal-title":"Rus J Cardiol"},{"issue":"1","key":"1926_CR5","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/j.1467-789X.2009.00623.x","volume":"11","author":"MM Ibrahim","year":"2010","unstructured":"Ibrahim MM. Subcutaneous and visceral adipose tissue: structural and functional differences. Obes Rev. 2010;11(1):11\u20138.","journal-title":"Obes Rev"},{"issue":"14","key":"1926_CR6","doi-asserted-by":"publisher","first-page":"2977","DOI":"10.1113\/JP276747","volume":"598","author":"M Nakamura","year":"2020","unstructured":"Nakamura M, Sadoshima J. Cardiomyopathy in obesity, insulin resistan-ce and diabetes. J Physiol. 2020;598(14):2977\u201393. https:\/\/doi.org\/10.1113\/JP276747.","journal-title":"J Physiol"},{"key":"1926_CR7","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.3389\/fphys.2018.01866","volume":"9","author":"A Al\u00ed","year":"2019","unstructured":"Al\u00ed A, Boutjdir M, Aromolaran AS. Cardiolipotoxicity, inflammation, an-d arrhythmias: role for interleukin-6 molecular mechanisms. Front Physiol. 2019;9:1866.","journal-title":"Front Physiol"},{"issue":"4","key":"1926_CR8","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1161\/CIRCRESAHA.117.311586","volume":"122","author":"G Jia","year":"2018","unstructured":"Jia G, Hill MA, Sowers JR. Diabetic cardiomyopathy: an update of mechanisms contributing to this clinical entity. Circ Res. 2018;122(4):624\u201338.","journal-title":"Circ Res"},{"issue":"1","key":"1926_CR9","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1186\/s12933-022-01670-x","volume":"21","author":"T Qiao","year":"2022","unstructured":"Qiao T, Luo T, Pei H, et al. Association between abdominal obesity indices and risk of cardiovascular events in Chinese populations with type 2 diabetes: a prospective cohort study. Cardiovasc Diabetol. 2022;21(1):225.","journal-title":"Cardiovasc Diabetol"},{"issue":"23","key":"1926_CR10","first-page":"00199","volume":"S0939\u20134753","author":"W Zhou","year":"2023","unstructured":"Zhou W, Zhu L, Yu Y, Yu C, Bao H, Cheng X. A Body shape index is positively associated with all-cause and cardiovascular disease mortality in the Chinese population with normal weight: a prospective cohort study. Nutr Metab Cardiovasc Dis. 2023;S0939\u20134753(23):00199.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"1","key":"1926_CR11","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jacc.2016.03.597","volume":"68","author":"E Levelt","year":"2016","unstructured":"Levelt E, Pavlides M, Banerjee R, et al. Ectopic and visceral fat dep-osition in lean and obese patients with type 2 diabetes. J Am Coll Cardiol. 2016;68(1):53\u201363.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"1926_CR12","doi-asserted-by":"publisher","first-page":"e001979","DOI":"10.1161\/CIRCIMAGING.114.001979","volume":"8","author":"M Gran\u00e9r","year":"2014","unstructured":"Gran\u00e9r M, Nyman K, Siren R, et al. Ectopic fat depots and left ventri-cular function in nondiabetic men with nonalcoholic fatty liver diseas-e. Circ Cardiovasc Imaging. 2014;8(1):e001979.","journal-title":"Circ Cardiovasc Imaging"},{"issue":"6","key":"1926_CR13","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1111\/obr.12407","volume":"17","author":"L Li","year":"2016","unstructured":"Li L, Liu DW, Yan HY, et al. Obesity is an independent risk factor fo-r non-alcoholic fatty liver disease: evidence from a meta-analysis of 21 cohort studies. Obes Rev. 2016;17(6):510\u20139.","journal-title":"Obes Rev"},{"issue":"4","key":"1926_CR14","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1089\/met.2019.0115","volume":"18","author":"K Lechner","year":"2020","unstructured":"Lechner K, McKenzie AL, Kr\u00e4nkel N, et al. High-risk atherosclerosis and metabolic phenotype: the roles of ectopic adiposity, atherogeni-c dyslipidemia, and inflammation. Metab Syndr Relat Disord. 2020;18(4):176\u201385.","journal-title":"Metab Syndr Relat Disord"},{"issue":"8","key":"1926_CR15","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/j.metabol.2016.01.012","volume":"65","author":"Y Fazel","year":"2016","unstructured":"Fazel Y, Koenig AB, Sayiner M, Goodman ZD, Younossi ZM. Epidemi-ology and natural history of non-alcoholic fatty liver disease. Metabolis-m. 2016;65(8):1017\u201325.","journal-title":"Metabolis-m"},{"issue":"1","key":"1926_CR16","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","volume":"15","author":"Z Younossi","year":"2018","unstructured":"Younossi Z, Anstee QM, Marietti M, et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2018;15(1):11\u201320.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"41","key":"1926_CR17","doi-asserted-by":"publisher","first-page":"49","DOI":"10.7748\/ns2009.06.23.41.49.c7050","volume":"23","author":"M Ashwell","year":"2009","unstructured":"Ashwell M. Obesity risk: importance of the waist-to-height ratio. Nurs- Stand. 2009;23(41):49\u201355.","journal-title":"Nurs- Stand"},{"key":"1926_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.soard.2022.12.016","author":"E Sheikhbahaei","year":"2022","unstructured":"Sheikhbahaei E, Tavassoli Naini P, Agharazi M, et al. Cardiac fat pat change after laparoscopic sleeve gastrectomy and roux-en-Y gastric bypass surgery: a systematic review and meta-analysis. Surg Obes Relat Dis. 2022. https:\/\/doi.org\/10.1016\/j.soard.2022.12.016.","journal-title":"Surg Obes Relat Dis"},{"issue":"6","key":"1926_CR19","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.2337\/diacare.27.6.1487","volume":"27","author":"TM Wallace","year":"2004","unstructured":"Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA model-ing. Diabetes Care. 2004;27(6):1487\u201395.","journal-title":"Diabetes Care"},{"issue":"1","key":"1926_CR20","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","volume":"67","author":"N Chalasani","year":"2018","unstructured":"Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and manage-ment of nonalcoholic fatty liver disease: practice guidance from the A-merican association for the study of liver diseases. Hepatology. 2018;67(1):328\u201357.","journal-title":"Hepatology"},{"issue":"4","key":"1926_CR21","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1002\/hep.21496","volume":"45","author":"P Angulo","year":"2007","unstructured":"Angulo P, Hui JM, Marchesini G, et al. The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFL-D. Hepatology. 2007;45(4):846\u201354.","journal-title":"Hepatology"},{"issue":"8","key":"1926_CR22","doi-asserted-by":"publisher","first-page":"5424","DOI":"10.1007\/s00330-022-08629-2","volume":"32","author":"J Xu","year":"2022","unstructured":"Xu J, Yang W, Zhao S, Lu M. State-of-the-art myocardial strain by C-MR feature tracking: clinical applications and future perspectives. Eur- Radiol. 2022;32(8):5424\u201335.","journal-title":"Eur- Radiol"},{"issue":"1","key":"1926_CR23","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3945\/ajcn.115.111203","volume":"102","author":"L Schweitzer","year":"2015","unstructured":"Schweitzer L, Geisler C, Pourhassan M, et al. What is the best referen-ce site for a single MRI slice to assess whole-body skeletal muscle an-d adipose tissue volumes in healthy adults? Am J Clin Nutr. 2015;102(1):58\u201365.","journal-title":"Am J Clin Nutr"},{"issue":"2","key":"1926_CR24","doi-asserted-by":"publisher","first-page":"389","DOI":"10.2337\/dc11-1820","volume":"35","author":"S Bonapace","year":"2012","unstructured":"Bonapace S, Perseghin G, Molon G, et al. Nonalcoholic fatty liver dis-ease is associated with left ventricular diastolic dysfunction in patients with type 2 diabetes. Diabetes Care. 2012;35(2):389\u201395.","journal-title":"Diabetes Care"},{"issue":"4","key":"1926_CR25","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.jhep.2012.11.015","volume":"58","author":"K Hallsworth","year":"2013","unstructured":"Hallsworth K, Hollingsworth KG, Thoma C, et al. Cardiac structure an-d function are altered in adults with non-alcoholic fatty liver disease. J Hepatol. 2013;58(4):757\u201362.","journal-title":"J Hepatol"},{"issue":"1","key":"1926_CR26","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12933-020-01201-6","volume":"20","author":"K VanHirose","year":"2021","unstructured":"VanHirose K, Nakanishi K, Daimon M, et al. Impact of insulin resista-nce on subclinical left ventricular dysfunction in normal weight and ov-erweight\/obese japanese subjects in a general community. Cardiovasc Diabetol. 2021;20(1):22.","journal-title":"Cardiovasc Diabetol"},{"issue":"8","key":"1926_CR27","doi-asserted-by":"publisher","first-page":"e017371","DOI":"10.1161\/JAHA.120.017371","volume":"10","author":"G Styczynski","year":"2021","unstructured":"Styczynski G, Kalinowski P, Micha\u0142owski \u0141, et al. Cardiac morpholog-y, function, and hemodynamics in patients with morbid obesity and nonalcoholic steatohepatitis. J Am Heart Assoc. 2021;10(8):e017371.","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"1926_CR28","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s12933-023-01828-1","volume":"22","author":"Y Qu","year":"2023","unstructured":"Qu Y, Liu J, Li J, et al. Association of abdominal adiposity, hepatic s-hear stiffness with subclinical left-ventricular remodeling evaluated by magnetic resonance in adults free of overt cardiovascular diseases: a pr-ospective study. Cardiovasc Diabetol. 2023;22(1):99.","journal-title":"Cardiovasc Diabetol"},{"issue":"12","key":"1926_CR29","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1016\/j.jcmg.2015.11.001","volume":"8","author":"P Claus","year":"2015","unstructured":"Claus P, Omar AMS, Pedrizzetti G, Sengupta PP, Nagel E. Tissue tra-cking technology for assessing cardiac mechanics: principles, normal values, and clinical applications. JACC Cardiovasc Imaging. 2015;8(12):1444\u201360.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"1","key":"1926_CR30","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1161\/CIRCULATIONAHA.107.728550","volume":"117","author":"L van Heerebeek","year":"2008","unstructured":"van Heerebeek L, Hamdani N, Handoko ML, et al. Diastolic stiffness of the failing diabetic heart: importance of fibrosis, advanced glycation- end products, and myocyte resting tension. Circulation. 2008;117(1):43\u201351.","journal-title":"Circulation"},{"issue":"1","key":"1926_CR31","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/s12933-022-01660-z","volume":"21","author":"H Deng","year":"2022","unstructured":"Deng H, Hu P, Li H, et al. Novel lipid indicators and the risk of type 2 diabetes mellitus among Chinese hypertensive patients: findings from the Guangzhou heart study. Cardiovasc Diabetol. 2022;21(1):212.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"1926_CR32","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12933-022-01464-1","volume":"21","author":"Z Wu","year":"2022","unstructured":"Wu Z, Yu S, Kang X, et al. Association of visceral adiposity index with incident nephropathy and retinopathy: a cohort study in the diabetic population. Cardiovasc Diabetol. 2022;21(1):32.","journal-title":"Cardiovasc Diabetol"},{"issue":"14","key":"1926_CR33","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1056\/NEJMra0912063","volume":"363","author":"G Targher","year":"2010","unstructured":"Targher G, Day CP, Bonora E. Risk of cardiovascular disease in patie-nts with nonalcoholic fatty liver disease. N Engl J Med. 2010;363(14):1341\u201350.","journal-title":"N Engl J Med"},{"issue":"9","key":"1926_CR34","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/nrendo.2017.56","volume":"13","author":"YH Lai","year":"2017","unstructured":"Lai YH, Su CH, Hung TC, Association of NoMeex RCR, Watt MJ, et al. Hepatokines: linking nonalcoholic fatty liver disease and insulin re-sistance. Nat Rev Endocrinol. 2017;13(9):509\u201320.","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"1926_CR35","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1002\/ehf2.12222","volume":"5","author":"A Yoshihisa","year":"2018","unstructured":"Yoshihisa A, Sato Y, Yokokawa T, et al. Liver fibrosis score predicts mortality in heart failure patients with preserved ejection fraction. ESC Heart Fail. 2018;5(2):262\u201370.","journal-title":"ESC Heart Fail"},{"issue":"1","key":"1926_CR36","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12933-017-0528-4","volume":"16","author":"N Gonz\u00e1lez","year":"2017","unstructured":"Gonz\u00e1lez N, Moreno-Villegas Z, Gonz\u00e1lez-Bris A, Egido J, Lorenzo \u00d3. Regulation of visceral and epicardial adipose tissue for preventing car-diovascular injuries associated to obesity and diabetes. Cardiovasc Diabetol. 2017;16(1):44.","journal-title":"Cardiovasc Diabetol"},{"issue":"18","key":"1926_CR37","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1161\/01.CIR.0000127959.28627.F8","volume":"109","author":"LR Peterson","year":"2004","unstructured":"Peterson LR, Herrero P, Schechtman KB, et al. Effect of obesity and i-nsulin resistance on myocardial substrate metabolism and efficiency in young women. Circulation. 2004;109(18):2191\u20136.","journal-title":"Circulation"},{"key":"1926_CR38","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/978-3-319-48382-5_12","volume":"960","author":"D Yaz\u0131c\u0131","year":"2017","unstructured":"Yaz\u0131c\u0131 D, Sezer H. Insulin resistance, obesity and lipotoxicity. Adv Exp Med Biol. 2017;960:277\u2013304.","journal-title":"Adv Exp Med Biol"},{"issue":"3","key":"1926_CR39","doi-asserted-by":"publisher","first-page":"408","DOI":"10.3390\/diagnostics11030408","volume":"11","author":"YH Lai","year":"2021","unstructured":"Lai YH, Liu LY, Sung KT, et al. Diverse adiposity and atrio-ventricular dysfunction across obesity phenotypes: implication of epicardial fat analysis. Diagnostics (Basel). 2021;11(3):408.","journal-title":"Diagnostics (Basel)"},{"key":"1926_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mri.2021.03.015","volume":"80","author":"JH Ahn","year":"2021","unstructured":"Ahn JH, Yu JS, Park KS, et al. Effect of hepatic steatosis on native T1 mapping of 3T magnetic resonance imaging in the assessment of T-1 values for patients with non-alcoholic fatty liver disease. Magn Reson Imaging. 2021;80:1\u20138.","journal-title":"Magn Reson Imaging"},{"issue":"1","key":"1926_CR41","first-page":"118","volume":"28","author":"L Papalavrentios","year":"2015","unstructured":"Papalavrentios L, Sinakos E, Chourmouzi D, et al. Value of 3 Tesla diffus-ion-weighted magnetic resonance imaging for assessing liver fibrosis. Ann Gastroenterol. 2015;28(1):118\u201323.","journal-title":"Ann Gastroenterol"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-023-01926-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-023-01926-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-023-01926-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T10:20:18Z","timestamp":1700389218000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-023-01926-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,10]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1926"],"URL":"https:\/\/doi.org\/10.1186\/s12933-023-01926-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3038637\/v1","asserted-by":"object"}]},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,10]]},"assertion":[{"value":"8 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by our Institutional Review Board. Informed written consent was obtained from each subject.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent for publication was obtained from each subject.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"206"}}